Iovance Biotherapeutics logo

Iovance Biotherapeutics

Iovance Biotherapeutics (NASDAQ: IOVA) aims to improve patient care for people living with cancer. Iovance is investigating T cell-based therapies, known as tumor infiltrating lymphocytes (TIL), which use a patient’s own immune cells to attack cancer.

Industries

Employees

201-500

Links


Org chart

Collapse

Board & advisors


Teams


Offices